Link Between Sleep Difficulties and Cataract Development in Adults in the United States: A Cross-Sectional Analysis

• by Jun Huang, Yulan Zhang, Chao Wu, Chen Wu, Yifan Wu, Feiran Wang, Lu Shi

• April 23, 2026

Utilizing Active Fluidics at Reduced Intraocular Pressure Alleviates Intraoperative Discomfort During Phacoemulsification: A Propensity Score-Matched Analysis

• by Yuanjiao Qiao, Ye Ye, Fangyan Liu, Lishi Luo, Xiaosheng Huang, Biyun Liang, Wenqun Xi, Xinhua Liu, Kun Zeng

• April 22, 2026

The Myopia Control Kit

Thomas Aller, OD, provides in-depth overviews of each myopia management option—pharmacologic therapy, soft contact lenses, orthokeratology, spectacle lenses, and environmental and behavioral interventions—so clinicians can not only provide the right option to each patient, but also address the larger economic and societal burdens of myopia.

• by Thomas Aller, OD

• May 1, 2026

• 11 min

IL-6 Inhibitor Vamikibart Shows Efficacy Signals in DME Trial

At ARVO 2026, Arshad M. Khanani, MD, MA, FASRS, presented phase 2 data on vamikibart, an IL-6 inhibitor, in diabetic macular edema.

• by Arshad M. Khanani, MD, MA, FASRS, Arshad M. Khanani, MD, MA, FASRS

• May 1, 2026

• 4 min